Vice President, Global and US Market Access

Nurix Therapeutics is a clinical stage biopharmaceutical company focused on the discovery, development, and commercialization of targeted protein degradation medicines. These medicines represent the next frontier in innovative drug design aimed at improving treatment options for patients with cancer and inflammatory diseases. Powered by a fully AI-integrated discovery engine and unparalleled ligase expertise, Nurix’s team translates the science of targeted protein degradation into clinical advancements, aiming to establish degrader-based treatments at the forefront of patient care.

About the role

This pivotal leadership role on the Nurix Commercial Leadership Team (CLT) will architect the global value, pricing, and access strategy for the Nurix portfolio. The VP of Global and US Market Access will co-lead the end-to-end US launch of Nurix's first hematology product in close collaboration with a global pharmaceutical partner.

Responsibilities

• Develop and lead the overarching framework for demonstrating and communicating product value to payers, HTAs, and health systems globally, including coordination with a global pharmaceutical partner to align on international access strategies.
• Design US payer engagement strategies to secure broad, sustainable reimbursement.
• Build patient support services programs that remove access barriers and ensure patients can start and stay on therapy.
• Develop pricing architecture and contracting strategies that balance access, value, and business sustainability.
• Oversee specialty pharmacy, distributor, and GPO plans to ensure reliable product availability.
• Develop a strategic engagement plan with IDNs, academic medical centers, and high-value accounts.
• Serve as a core member of the CLT, partnering closely with Marketing, Sales, Medical Affairs, and Analytics to align commercial strategy.
• Act as the primary Market Access point of contact with a global strategic partner, ensuring alignment on value messaging, access strategy, and timelines.
• Lead launch readiness planning across all access functions to ensure flawless execution at launch.
• Collaborate with HEOR and Medical Affairs to build a compelling value proposition, evidence generation plan, and economic models that resonate with payers.
• Leverage data and analytics to continuously sharpen strategy and measure impact.
• Advise senior leadership and the Board on evolving market trends, policy shifts, and their implications for the business.
• Partner with Legal, Compliance, Finance, and Accounting to ensure all strategies are sound and compliant.
• Contribute market access expertise to early-pipeline planning, laying groundwork for future launches.

Qualifications

• 15+ years' experience in the pharma or biotech industry, with at least 5–7 years in senior market access leadership.
• Deep expertise across payer strategy, pricing, contracting, trade, and patient services.
• Strong hematology/oncology experience highly preferred.
• Experience navigating complex partnerships or co-commercialization arrangements with large pharmaceutical companies, including alignment on access strategy and cross-functional coordination.
• Proven ability to build and lead both internal and field-based teams in fast-moving, high-growth environments.
• Track record of making decisive calls while fostering a collaborative, compliant culture.
• Exceptional communicator — equally effective with field teams, the C-suite, and the Board.

Location

Onsite preferred.

Fit with Nurix Culture and Values

• Strong team orientation; highly collaborative.
• Solutions and results-oriented focus.
• Hands-on approach; resourceful and open to diverse points of view.

Pay

Salary range: $325,000 – $365,000 plus bonus and equity.